- Leverages the latest technologies to simplify processes with Effortless Workflow, a new artificial intelligence (AI) suite that reduces the number of clicks necessary to execute a CT exam by 66%[i] and helps clinicians deliver more personalized medicine – optimizing scan range settings, dose and image quality for each patient
- Accommodates a greater variety of patients with its new 75 cm wide-gantry and enhances patient comfort with 21% faster exams[ii]
- Uses a dedicated deep neural network to generate T
For media inquiries, please contact:
Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
Chicago/Helsingborg, Sweden July 9, 2021: GE Healthcare announces the integration of Spectronic Medical AB AI-based software[1] for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.
For media inquiries, please contact:
Hannah Huntly+44 7887 824201
[email protected]
Europe/London Margaret Steinhafel
+1 608 381 8829
[email protected]
America/Chicago
business unit
- GE Healthcare launches Xeleris V, a new processing and review solution that provides nuclear medicine clinicians secure access to data from anywhere, anytime
- Featuring new Artificial Intelligence-enabled (AI) applications, the solution also simplifies and enhances workflows and provides clinicians with the advanced data needed to help them make personalized care decisions and treatment recommendations that are at the heart of precision health
CHICAGO, 10 May 2021 – To help provide nuclear medicine clinicians greate
For media inquiries, please contact:
1 608 381 8829
[email protected]
business unit
[FOR EUROPEAN MEDIA]
For media inquiries, please contact:
Margaret SteinhafelGE Healthcare
+1 608 381 8829
[email protected]
business unit
GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)
For media inquiries, please contact:
Margaret SteinhafelGE Healthcare
+1 608 381 8829
[email protected]
business unit
- GE Healthcare continues to provide tools to support clinicians in today’s COVID-19 environment
- Thoracic Care Suite harnesses the power of AI to scan for eight chest x-ray abnormalities, including pneumonia indicative of COVID-19 – a key cause of mortality in patients who contract coronavirus [1]
- The AI suite, featuring Lunit INSIGHT CXR [2], also includes an algorithm to detect tuberculosis, which affects approximately 10 m
For media inquiries, please contact:
Margaret Steinhafel
+1 608 381 8829
[email protected]
America/Chicago
business unit
Buc, France – December 2, 2019 – GE Healthcare and Affidea, the pan-European leader in advanced diagnostic imaging, outpatient and cancer care services, have signed a multi-year agreement to deploy imaging and digital technologies across the Affidea network.
GE Healthcare will install 200+ new equipment in Affidea’s network of centers across Europe. The deal includes the provision of 60 new MRIs, 50 ultrasound devices, 40 CT scanners and 30 X-rays machines in the next 3 years. It also includes a six-year service contract.
For media inquiries, please contact:
Melania PopielEastern Europe Communications Manager
GE Healthcare
+48 504 455 345
[email protected] Oana Dumitroiu
Head of Brand & Communication
Affidea
+40 738 674 320
[email protected]
business unit
- Total orders of $28.7 billion, down 4%; organic orders up 4%; total revenues (GAAP) of $28.8 billion, down 1%; Industrial segment organic revenues (non-GAAP) of $27.7 billion, up 7%
- GE Industrial profit margin (GAAP) of (1.3)%; adjusted GE Industrial profit margin (non-GAAP) of 7.6%
- Continuing EPS (GAAP) of $(0.03); adjusted EPS (non-GAAP) of $0.17, including $0.06 benefit from tax audit resolution
- Non-cash goodwill impairment charge of $744 million pre-tax related to Grid Solutions equipment and services, resulting in $(0.09) impact to
business unit
tags
- Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualized treatment
- Partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics and sequencing portfolio
Chicago, USA Jan 8, 2018 - GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointl